Award details

Unlocking high-throughput analysis within the RNA epigenetics domain

ReferenceBB/S004947/1
Principal Investigator / Supervisor Professor Anastasia Callaghan
Co-Investigators /
Co-Supervisors
Institution University of Portsmouth
DepartmentInst of Biomedical and Biomolecular Sc
Funding typeResearch
Value (£) 202,097
StatusCompleted
TypeResearch Grant
Start date 01/04/2019
End date 30/09/2021
Duration30 months

Abstract

unavailable

Summary

In the rapidly emerging field of RNA epigenetics, reversible chemical modifications of RNA by writer, reader and eraser proteins are known to play key roles in changing RNA activity and regulating critical cellular processes. Mass spectrometry and sequencing techniques are used to detect RNA modifications, but neither are capable of high-throughput analysis. To support the exponential growth of research in this field there is an urgent need for high-throughput approaches. Working with RNA epigenetics experts, Storm Therapeutics, this goal can be achieved by repurposing our patented RNA array platform technology to facilitate simultaneous analysis of multiple target RNAs for RNA modification detection. With market exclusivity, the tailoring of our RNA array into the RNA epigenetics domain offers a very significant increase in its utility, greatly increasing its market potential and substantially enhancing its attractiveness to potential licensees.
Committee Not funded via Committee
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative Follow-On Fund (FOF) [2004-2015]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file